tirzepatide surpass Patient-Reported Outcomes in People with Type 2 Diabetes Receiving in the Clinical Trial Programme | Diabetes Therapy SURPASS-CVOT trial results: Tirzepatide's impact

Future studies should further investigate the mechanistic pathways of GLP-1 RAs, prescribing patterns in diverse populations, and evaluate their efficacy in patients with [heart failure] with preserved ejection fraction and lower BMI through randomized clinical trials, the authors wrote.

Wegovy conducted a study with 1,900 adults who were obese or overweight with comorbidity (high blood pressure or high cholesterol) and found that people lost a median of 15% of their weight while on a target weight loss dose of medication (2.4 mg/week)

The cost of an insulated medication travel case

When the trigger foods for a patient's sulfur burps are specifically these high-FODMAP vegetables, adding Beano or a generic equivalent (300-450 GalU per meal) taken just before eating may reduce substrate load